298 related articles for article (PubMed ID: 28342227)
1. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
[TBL] [Abstract][Full Text] [Related]
4. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
[TBL] [Abstract][Full Text] [Related]
6. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
Clement C; Capriotti JA; Kumar M; Hobden JA; Foster TP; Bhattacharjee PS; Thompson HW; Mahmud R; Liang B; Hill JM
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):339-44. PubMed ID: 20702820
[TBL] [Abstract][Full Text] [Related]
7. [Epidemic keratoconjunctivitis: treatment results during an epidemic].
Hutter H
Klin Monbl Augenheilkd; 1990 Sep; 197(3):214-7. PubMed ID: 1701507
[TBL] [Abstract][Full Text] [Related]
8. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.
Shorter E; Whiteside M; Harthan J; Margolis MS; Hartwick AT; Johnson S; Migneco M; Morettin C; Olson CK; Huecker J; Than T; Gordon MO
Ocul Surf; 2019 Oct; 17(4):828-832. PubMed ID: 31401340
[TBL] [Abstract][Full Text] [Related]
10. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
Bekmez S; Eris E
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
[No Abstract] [Full Text] [Related]
11. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.
Wilkins MR; Khan S; Bunce C; Khawaja A; Siriwardena D; Larkin DF
Br J Ophthalmol; 2011 Sep; 95(9):1299-303. PubMed ID: 21252084
[TBL] [Abstract][Full Text] [Related]
12. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.
Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A
Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Jeng BH; Holsclaw DS
Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
Bhargava R; Kumar P
Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215
[TBL] [Abstract][Full Text] [Related]
15. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.
Gordon YJ; Araullo-Cruz T; Romanowski EG
Arch Ophthalmol; 1998 Jul; 116(7):900-5. PubMed ID: 9682703
[TBL] [Abstract][Full Text] [Related]
16. Povidone iodine in the treatment of adenoviral conjunctivitis in infants.
Özen Tunay Z; Ozdemir O; Petricli IS
Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746
[TBL] [Abstract][Full Text] [Related]
17. Determinants of Outcomes of Adenoviral Keratoconjunctivitis.
Lee CS; Lee AY; Akileswaran L; Stroman D; Najafi-Tagol K; Kleiboeker S; Chodosh J; Magaret A; Wald A; Van Gelder RN;
Ophthalmology; 2018 Sep; 125(9):1344-1353. PubMed ID: 29602567
[TBL] [Abstract][Full Text] [Related]
18. Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study.
Trinavarat A; Atchaneeyasakul LO
J Ocul Pharmacol Ther; 2012 Feb; 28(1):53-8. PubMed ID: 21916618
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
Ghanem RC; Vargas JF; Ghanem VC
Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
[TBL] [Abstract][Full Text] [Related]
20. A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
Ta CN; Raizman MB; Gross RD; Joshi S; Mallick S; Wang Y; Segal B
Am J Ophthalmol; 2020 Jul; 215():56-65. PubMed ID: 32222367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]